MetLife Inc. [NYSE: MET] loss -5.48% on the last trading session, reaching $58.96 price per share at the time. The company report on March 10, 2023 that MetLife Honored as a Member of the 2023 Bloomberg Gender-Equality Index.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
MetLife, Inc. (NYSE: MET) announced that for the eighth consecutive year it has been named to the Bloomberg Gender-Equality Index (GEI), which tracks the performance of public companies that report gender-related data.
MetLife Inc. represents 783.70 million in outstanding shares, while the company has a total market value of $47.33 billion with the latest information. MET stock price has been found in the range of $58.44 to $60.65.
If compared to the average trading volume of 4.10M shares, MET reached a trading volume of 10245182 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about MetLife Inc. [MET]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MET shares is $83.64 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MET stock is a recommendation set at 2.10. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Goldman have made an estimate for MetLife Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on January 09, 2023. While these analysts kept the previous recommendation, Jefferies dropped their target price from $86 to $82. The new note on the price target was released on December 09, 2022, representing the official price target for MetLife Inc. stock. On June 23, 2022, analysts increased their price target for MET shares from 70 to 74.
The Average True Range (ATR) for MetLife Inc. is set at 1.91, with the Price to Sales ratio for MET stock in the period of the last 12 months amounting to 0.68. The Price to Book ratio for the last quarter was 1.71, with the Price to Cash per share for the same quarter was set at 25.16. Price to Free Cash Flow for MET in the course of the last twelve months was 4.08.
Trading performance analysis for MET stock
MetLife Inc. [MET] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -15.40. With this latest performance, MET shares dropped by -16.71% in over the last four-week period, additionally sinking by -12.83% over the last 6 months – not to mention a drop of -8.28% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MET stock in for the last two-week period is set at 15.98, with the RSI for the last a single of trading hit 10.05, and the three-weeks RSI is set at 21.39 for MetLife Inc. [MET]. The present Moving Average for the last 50 days of trading for this stock 70.77, while it was recorded at 64.55 for the last single week of trading, and 68.01 for the last 200 days.
MetLife Inc. [MET]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and MetLife Inc. [MET] shares currently have an operating margin of +5.43. MetLife Inc.’s Net Margin is presently recorded at +3.63.
MetLife Inc. [MET]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MET. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for MetLife Inc. go to 6.09%.
An analysis of insider ownership at MetLife Inc. [MET]
There are presently around $33,752 million, or 75.50% of MET stock, in the hands of institutional investors. The top three institutional holders of MET stocks are: VANGUARD GROUP INC with ownership of 55,519,588, which is approximately -1.509% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 55,515,781 shares of the stock with an approximate value of $3.27 billion in MET stocks shares; and DODGE & COX, currently with $3.16 billion in MET stock with ownership of nearly -4% of the company’s market capitalization.
Positions in MetLife Inc. stocks held by institutional investors increased at the end of Wednesday and at the time of the Wednesday reporting period, where 634 institutional holders increased their position in MetLife Inc. [NYSE:MET] by around 28,666,871 shares. Additionally, 574 investors decreased positions by around 33,784,084 shares, while 188 investors held positions by with 510,000,616 shares. The mentioned changes placed institutional holdings at 572,451,571 shares, according to the latest SEC report filing. MET stock had 206 new institutional investments in for a total of 5,809,676 shares, while 71 institutional investors sold positions of 1,652,738 shares during the same period.